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Abstract
The mitochondrial, the microsomal, and the supernatant fractions were prepared from the cell
homogenate of tumors induced by viruses, such as adenovirus type 12, SV 40, and Rous sarcoma
virus, etc. and the antigenicities of these fractions were investigated. In the virus-induced tumors,
there existed no antigenicity common to the mitochondrial and the microsomal fractions as in
the tumors induced by chemical carcinogens, and the highest antigenicity was recognized in the
mitochondrial fraction. Therefore, the properties of the tumor cell mitochondria were precisely
investigated with virus-induced tumor mitochondria. 1. The mitochondria of tumors induced by
viruses have clearly the specific antigenicity. 2. This specific antigenicity of virus.induced tumor
mitochondria IS common to all the virus-induced tumors used in the present study. 3. This tumor
mitochondria.specific antigenicity is found commonly in all the tumor mitochondria in the present
experiments. 4. The specific cancer antigenicity of tumor cell mitochondria does not exist in
normal organ mitochondria, but the regenerating organ mitochondria exhibit a slight antigenicity
common to cancer cell mitochondria.
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Since WITEBSKY (1) first reported about the existence of specific can-
cer antigens, immunological studies on the cancer specificities have begun,
and numerous efforts have been made to investigate the specific cancer
antigenicity. With the improvement in cell fractionation methods and
immunochemical procedures, many reports have appeared suggesting the
existence of specific cancer antigenicity in cancer cell mitochondria, by
fractionating the cancer cells into membrane fractions at subcellular level
and by comparing their antigenicities (2-9). On the other hand, the
investigators looking for the cause of cancer at viruses searched for the
specific cancer antigenicities to be originated in viruses by immunofluores-
cent technique (10-23) or ferritin antibody technique (24-30), and
recently viral genome has also come to be investigated from the aspect of
nucleic acids. As the specific cancer antigenicity was forturnately found
in cancer cell mitochondria, and its properties were analysed pecisely in
previous reports (31, 32), subcellular components of virus-induced tumor
cells were fractionated by ultracentrifugation and the immunospecificities
of each of these fractions were observed chiefly by immunodiffusion
methods, in view of the possibility that the same methods described in the
previous reports can be applied to virus-induced tumors. As the result
some very interesting findings obtained are reported in this paper.
MATERIALS AND METHODS
Inbred C3H mice, hamsters, and Donryu rats were used in this ex-
periments. The cancer strains used were SR-RSV.induced mouse sarcoma
(SR-C3HjHe ascites), adenovirus type 12-induced hamster tumor, SV 40-
induced hamster tumor, and AH130 rat ascites hepatoma. SR.C3H sarcoma
was obtained through the courtesy of Prof. T. YAMAMOTO, Department of
This investagation was supported by a grant from the Japan Ministry of Education.
105
1
Wakabayashi: Immunological studies on the membrane systems of cancer cells. 3.
Produced by The Berkeley Electronic Press, 1969
106 A. WAKABAYASHI
Oncology, Institute for Medical Science, University of Tokyo, Shiba-Shirokane,
Tokyo (33,34). The other experimental groups were the livers of various kinds of
tumor-bearing animals, rat livers, human liver and spleen from the same person.
Isolation of mitochondria: Tumor mitochondria, and liver and spleen mito-
chondria were isolated by the modification of the method of HOGEBOOM (35).
a) Tumor cell mitochondria of ascites form (the mitochondria of AH130 and
SR-C3H): These mitochondria were prepared by the method reported pre-
viously in Part II (32).
b) The mitochondria of the tumor induced by admovirus 0pe 12 or SV 40: Fresh
hamster tumors induced by adenovirus type 12 and induced by SV 40, after
elimenating necrotic tissues, were assembled, minced, and suspended in 0.25 M
cold sucrose solution containing 0.1 mM EDTA and 10 mM Tris-HCl, pH 7.6
at O°C before centrifugation. The suspension was blended by homoblender for
30 seconds, transferred to a glass tube. A loosely-fitted glass pestle of the
homogenizer was rotated, and the glass tube was moved up and down over
the pestle, and then a tightly-fitted teflon pestle was rotated and the glass tube
was moved up and down over the pestle the same as before. The homogenized
suspension was filtered through tetron cloth of double layer. The filtrate was
centrifuged at 700 x g for 10 minutes. By removing the residue, the superna-
tant was layered on an equal volume of 0.34 M sucrose solution containing
0.1 mM EDTA and 10 mM Tris-HCl, pH 7.6, then centrifuged at 800 x g
for 10 minutes. The upper layer was transferred to a centrifuge tube with a
pipette, and centrifuged at 5,000 x g for 10 minutes. After discarding the
supernatant, the residue (mitochondrial pellet) was washed twice with 0.25 M
sucrose solution containing 10 mM Tris-HCl, pH 7.6 by centrifugation at
9,000 x g for 10 minutes.
c) Normal and tumor-bearing animal liver mitochondria: Normal and tumor-
bearing animal liver mitochondria were prepared by the same method previ-
ously reported (32).
The other fractions were prepared using the same methods previously
reported (31). All the preparations were done at 0°-4°C.
White adult male rabbits weighing about 2 to 3 kg were used for the
purpose of immunization,
The immunizing procedure: Subcutaneous inoculation method was used. Each
rabbit was given several injections of 0.5 to 1.0 ml volumes of 30 mg of anti-
genic proteins incorporated into 3 ml of Freunds' complete adjuvant (Difco
Freunds' Adjuvant Complete) three times subcutaneously at the interval of
once a week in the middle between both shoulder blades.
Serum preparation method: Rabbit blood samples were collected from the
auricular vein on the 14th to 20th day after the last inoculation. These sam-
ples were allowed to clot at 20°C for one hour, then the serum was removed
from erythrocytes, and heated at 56°C for 30 minutes to inactivate complement.
Each serum titer was measured at once. However, the quantity of the mito-
chondria of tumors induced by adenovirus type 12 and induced by SV 40, was
insufficient to immunize the rabbit fully, so the pooled sera of tumor-bearing
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hamster were used for the immuno-reactions.
The determination of antigen-antibody reaction: Ouchterlony agar double diffu-
sion method was used for the determination of antigen-antibody reactions.
Difco Special Noble agar was used for double diffusion.
For the immunodiffusion in agar gel, a solution of l. 5 % agar in physiolo-
gical saline containing 0.01 % merthiolate was prepared. This agar solution
was poured into the disk of about 9 cm in diameter, and allowed to harden
to give a layer 3 to 5 mm thick. A central well and six circumferential wells
were punched out in such a way that each surrounding well was 6 mm apart
from the central well, making the center to center distance of central well to
each surrounding well 20 mm (Macro Ouchterlony method (36)).
An antiserum was poured into the central well and each test antigen was
poured into six surrounding wells. Before testing for those fractions proved to
be insoluble, each test antigen was dissolved with one % sodium deoxycholate
to give solubility and diffusibility in agar gel. Protein concentration of each
fraction was about 2 to 3 mg proteiniml. The samples were set at room
temperature for one hour, then changing the temperature of 0° to 4°C and
left overnight. After twenty-four hours, 48 hours and 72 hours, the reaction
was observed and photographed. Only the photographs taken at 72 hours
were used in this experiment for the comparison with others.
RESULTS
As the result of the cross-metching the rabbit·antiserum to AH130 rat
ascites hepatoma mitochondria (anti-AHMt serum) against the mitochon-
dria, microsomes, cell homogenate, and the supernatant (supernatant of
105, 000 x g, 30 min.) of SR-C3H mouse ascites sarcoma, and the mitochon-
dria and the microsomes of SR-C3H sarcoma-bearing mouse liver cells in
agar gel diffusion, it became evident that this antiserum reacted only of
SR-C3H sarcoma mitochondria, but it did not react on the microsomes,
the supernatant of SR-C3H, and the mitochondria and the microsomes
of SR-C3H-bearing mouse liver cells (Fig. 1 & Photo. 1)
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Fig. I The result of Ouchterlony central well contains the rabbit-
antiserum to AHl30 rat ascites hepatoma mitochondria. Surrounding
wells contain various antigens as illustrated below. I: SR-C3H
sarcoma mitochondria. 2: SR-C3H sarcoma microsomes. 3: SR-
C3H cell homogenate. 4: the supernatant of 105,000 X g, 30 min.
of SR-C3H sarcoma. 5: SR-C3H sarcoma-bearing mouse liver mito.
chondria. 6: SR.C3H sarcoma-bearing mouse liver microsomes.
In the cross-matchings in agar gel diffusion of the rabbit-antiserum
to SR-C3H mouse ascites sarcoma cell mitochondria (anti-SRC3HMt
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serum) against the mitochondria, microsomes, cell homogenate, and the
supernatant (sup. of 105,000 X g, 30 min.) of SR.C3H sarcoma cells, and
the mitochondria and the microsomes of SR.C3H sarcoma-bearing mouse
liver cells, it was also clear that only the mitochondria of the mouse
sarcoma cells react on this antiserum, forming the clear sharp precipitin
band, and other fractions did not respond at all. But the cell homogenate
of SR-C3H sarcoma cells slightly reacted on this serum, forming a weak
precipitin band (Fig. 2 & Photo. 2).
o0 _1;\nti- \J
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Fig. 2 The result of Ouchterlony central well contains the rabbit-
antiserum to SR-C3H sarcoma mitochondria. Surrounding wells con-
tain various antigens as illustrated below. 1: SR-C3H sarcoma
mitochondria. 2: SR-C3H sarcoma microsomes. 3: SR-C3H cell
homogenate. 4: the supernatant of 105,000 X g, 30 min. of SR-C3H
sarcoma, 5: SR-C3H sarcoma-bearing mouse liver mitochondria.
6: SR.C3H sarcoma-bearing mouse liver microsomes.
By cross-matching the pooled sera of hamsters bearing tumor induced
by adenovirus type 12 to the mitochondria, microsomes, cell homogenate,
and the supernatant (sup. of 105,000 x g, 30 min.) of SR-C3H mouse
ascites sarcoma cells, and the mitochondria and the microsomes of liver
cells of mouse bearing SR-C3H ascites sarcoma in agar gel diffusion, it
became clear as shown in Fig. 2 that only the mitochondria of this sarcoma
reacted on this pooled serum, forming a clear sharp precipitin band, and
none of the other fractions reacted at all. But the homogenate of SR-C3H
ascites sarcoma cells slightly reacted on this serum due to the existence of
the mitochondria in cell homogenate (Fig. 3).
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Fig. 3 The result of Ouchterlony central well contains the pooled
sera of hamsters bearing tumor induced by adenovirus type 12.
Surrounding wells contain various antigens as illustrated below.
1 : SR-C3H sarcoma mitochondria. 2: SR-C3H sarcoma microsomes.
3: SR-C3H cell homogenate. 4: the supernatant of 105,000 X g,
30 min. of SR-C3H sarcoma. 5: SR-C3H-bearing mouse liver mito-
chondria. 6: SR-C3H-bearing mouse liver microsomes.
In the cross.matchings in agar gel diffusion of the pooled sera of
hamsters bearing tumor induced by SV 40 virus to the mitochondria,
microsomes, cell homogenate, and the supernatant (sup. of 105,000 X g,
30 min.) of SR·C3H mouse ascites sarcoma cells, and the mitochondria
and the microsomes of liver cells of mouse bearing SR-C3H ascites sarcoma,
it became evident as Figs. 2 and 3 that only the mitochondria of this
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sarcoma cell reacted (Fig. 4).
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Fig. 4 The result of Ouchterlony central well contains the
pooled sera of hamsters bearing tumor induced by SV 40. Surround-
ing wells contain various antigens as illustrated below. l: SR-C3H
sarcoma mitochondria. 2: SR-C3H sarcoma microsomes. 3: SR-C3H
cell homogenate. 4: the supernatant of 105,000 x g, 30 min. of
SR-C3H sarcoma. 5: SR-C3H sarcoma-bearing mouse liver mitoc-
hondria. 6: SR-C3H sarcoma-bearing mouse liver microsomes.
From Figs. I, 2, 3, and 4, specific tumor antigenicity is contained in
the tumor cell mitochondria, which is common to various kinds of tumors
induced artificially in animals, but it has no connection with the kinds of
viruses as the carcinogens in precipitin reactions. This specific antigenicity
of the mitochondria of tumor cells induced by viruses seems to be the same
as that existed in the mitochondria of tumors induced by chemical carcino-
gens. So this tumor-specific mitochondrial antigenicity can possibly be
analysed more precisely in agar gel diffusion.
As the result of cross.matching in agar gel diffusion of the rabbit-anti.
serum to AHI30 rat ascites hepatoma cell mitochondria (anti-HMt serum)
against AHI30 hepatoma mitochondria, SR-C3H sarcoma mitochondria,
the mitochondria of hamster tumor induced by adenovirus type 12, the
liver mitochondria of rat bearing AHI30 hepatoma, of hamster bearing
tumor induced by adenovirus type 12, and of mouse bearing SR·C3H
sarcoma, this serum reacted on AHI30 mitochondria most remarkably,
SR-C3H sarcoma mitochondria slightly, and the mitochondria of hamster
tumor induced by adenovirus type 12 remarkably, but did not react on
the liver mitochondria of these tumor-bearing body (Fig. 5 & Photo. 3). It
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Fig. 5 The result of Ouchterlony central well contains the rabbit-
antiserum to AHl30 rat ascites hepatoma mitochondria. Surrounding
wells contain various a ntigens as illustrated below. HRTM: AHl30
hepatoma mitochondria. MTM: SR-C3H sarcoma mitochondria.
adHaTM: adenovirus type l2-induced hamster tumor mitochondria.
HRBM: AHl30 hepatoma-bearing rat liver mitochondria. SRVMBL:
SR-C3H sarcoma-beariug mouse liver mitochondria. adHaBM:
adenovirus type 12-iuduced tumor-bearing hamster liver mitochondria.
is considered that specific tumor antigenicity of tumor mitochondria does
not exist in the organ cell mitochondria of tumor-bearing body.
By the cross-reactions in agar gel diffusion of the rabbit-antiserum to
AH 130 rat ascites hepatoma cell mitochondria (anti-HMt serum) against
human liver mitochondria, beef heart mitochondria, and rat liver mito.
chondria, this antiserum reacted only slightly on rat liver mitochondria,
5
Wakabayashi: Immunological studies on the membrane systems of cancer cells. 3.
Produced by The Berkeley Electronic Press, 1969
110 A. WAKABAYASHI
forming the preClpltln band faintly, but both human liver mitochondria
and beef heart mitochondria had no reaction to this serum. This shows
that the organ mitochondria.specific antigenicities remain slightly in the
mitochondria of AH130 rat ascites hepatoma (Fig. 6 & Photo. 4).
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Fig. 6 result of Ouchterlony central well contains the rabbit-
antiserum to AHl30 rat ascites hepatoma mitochondria. Surrounding
wells contain various antigens as illustrated below. HRTM: AHl30
hepatoma mitochondria. MTM: SR-C3H sarcoma mitochondria.
ad HaTM: adenovirus type l2-induced hamster tumor mitochondria.
HLM: human liver mitochondria. BHM: beef heart mitochondria.
RLM: rat liver mitochondria.
By the cross.matchings in agar gel diffusion of the rabbit.antiserum to
SR-C3H mouse ascites sarcoma cell mitochondria (anti.SRC3HMt serum)
against AH130 hepatoma mitochondria, SR-C3H sercoma mitochondria,
the mitochondria of hamster tumor induced by adenovirus type 12, rat
liver mitochondria, liver mitochondria of the mouse bearing SR-C3H
sarcoma, and of the hamster bearing tumor induced by adenovirus type
12, this antiserum reacted remarkably on SR-C3H sarcoma mitochondria,
AH 130 hepatoma mitochondria and the mitochondria of hamster tumor
induced by adenovirus type 12, forming a clear sharp remarkable precipitin
band to those mitochondria. This fact shows that some tumor mitochon·
dria-specific tumor antigenicity common to chemical carcinogen-induced
tumor, RNA virus-induced tumor, and DNA virus-induced tumor, would
surely exist in tumor cell mitochondria (Fig. 7 & Photo. 5).
Fig.7 The result of Ouchterlony central well contains the rabbit-
antiserum to SR-C3H sarcoma mitochondria. Surroundin; wells con-
tain various antigens as illustrated below. RS: SR-C3H sarcoma
mitochondria. Ad: adenovirus type l2-induced hamster tumor mito.
chondria. H: AHl30 rat ascites hepatoma mitochondria. Rn: AHl30
hepatoma-bearing rat liver mitochondria. Mn: SR-C3H sarcoma-
bearing mouse liver mitochondria. Hn: adenovin:s type l2-induced
tumor-bearing hamster liver mitochondria.
From the results of cross.matching in agar gel of the rabbit-antiserum
to SR.C3H sarcoma mitochondria (anti-SRC3HMt serum) against the liver
mitochondria of rat bearing AH130 hepatoma, of mouse bearing SR-C3H
sarcoma and of hamster bearing tumor induced by adenovirus type 12,
neither AH 130 bearing-rat liver mitochondria nor adenovirus type l2-in.
duced tumor-bearing hamster liver mitochondria reacted on this serum,
but only the liver mitochondria of SR·C3H sarcoma-bearing mouse dis-
6
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Fig. 8 The result of Ouchterlony central well coutains the rabbit-
antiserum to SR-C3H sarcoma mitochondria. Surrounding wells con-
tain various antigens as illustrated below. HRTM: AHl30 hepatoma
mitochondria. MTM: SR-C3H sarcoma mitochondria. HaAdTM:
adenovirus type l2-induced hamster tumor mitochondria. HBRM:
AHl30 hepatoma-bearing rat liver mitochondria. RSVTBMLM:
SR-C3H sarcoma-bearing mouse liver mitochondria. HaAdLM:
adenovirus type 12-induced tumor-bearing hamster liver mitochondria.
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tinctly reacted on this serum (Fig. 8 & Photo. 6). This fact is thought to
be natural because the organ. or tissue.specific antigens of mouse remain
in SR·C3H sarcoma.
By cross·reactions carried in agar gel diffusion with the pooled sera of
hamsters bearing tumor induced by adenovirus type 12 (ad.12BHa serum)
to AHl30 hepatoma mitochondria, SR·C3H sarcoma mitochondria, the
mitochondria of hamster tumor induced by adenovirus type 12, and the
liver mitochondria of the rat bearing AH66F ascites hepatoma, of the
mouse bearing SR.C3H sarcoma, and of the hamster bearing tumor
induced by adenovirus type 12, it was clear that this serum reacted on
AHl30 hepatoma mitochondria, SR.C3H sarcoma mitochondria, and
adenovirus type 12·induced hamster tumor mitochondria most remarkably,
and reacted on the liver mitochondria of the hamster bearing tumor
induced by adenovirus type 12 very slightly, making a clear sharp precipi.
tin band remarkably, but did not react at all on the liver mitochondria of
the mouse bearing SR-C3H sarcoma (Fig. 9 & Photo. 7). These findings
8@ (3
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Fig. 9 The result of Ouchterlony central well contains pooled
sera of adenovirus type 12-induced tumor-bearing hamsters. Surround-
ing wells contain various antigens as illustrated below. HRTM: AHl30
rat ascites hepatoma mitochondria. MTM: SR-C3H sarcoma mito-
chondria. adHaTM: adenovirus type 12·induced hamster tumor mito-
chondria. FRBM: AH66F hepatoma-bearing rat liver mitochondria.
RSVMBL: SR-C3H sarcoma-bearing mouse liver mitochondria.
adHaBM: adenovirus type 12-induced tumor-bearing hamster liver
mitochondria.
demonstrate the presence of tumor mitochondria.specific tumor antigenicity
common to tumors of various kinds of various strains.
As the result of cross.matching in agar gel diffusion the ad·12BHa
serum to rat liver mitochondria, mouse liver mitochondria, human liver
mitochondria, the spleen mitochondria of the same human, and the liver
mitochondria of hamster bearing tumor induced by SV 40 and of mouse
bearing SR.C3H sarcoma, it became clear that these organ mitochondria
of various kinds and the liver mitochondria of hamster bearing tumor
7
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induced by SV 40 did not react at all on such pooled sera of hamsters
bearing tumor induced by adenovirus type 12 (Fig. 10 & Photo. 8). How-
ever, it was obvious that the liver mitochondria started to react on this
serum, when the precipitin reaction in agar gel set for 120 hours or more
(Fig. 11 & Photo. 9). This result suggests a possible existance of the cancer
10
11
Fig. 10 The result of Ouchterlony central well contains pooled
sera of adenovirus type l2-induced tumor-bearing hamsters. Surround-
ing wells contain various antigens as illustrated below. NRLM: rat
liver mitochondria. NMLM: mouse liver mitochondria. NHLM:
human liver mitochondria. HSM: human spleen mitochondria.
HaSVLM: SV 40-induced tumor-bearing hamster liver mitochondria.
RSVTBMLM: SR-C3H sarcoma-bearing mouse liver mitochondria.
Fig. 11 The result of Ouchterlony central well contains pooled
sera of adenovirus type l2-induced tumor-bearing hamsters. Surround-
ing wells contain various antigens as illustrated below. RS: SR-C3H
sarcoma mitochondria. Ad: adenovirus type l2·induced hamster
tumor mitochondria. H: AH130 hepatoma mitochondria. Rn: rat
liver mitochondria. Mn: mOl:se liver mitochondria. Hn: hamster
liver mitochondria.
mitochondria-specific cancer antigen-like substance in organ mitochondria,
or a possible disappearance of organ specific antigenicities in organ mito-
chondria of tumor.bearing body.
By the cross-matchings in agar gel diffusion of the pooled sera of
hamsters bearing tumor induced by SV 40 (SV 40.TBHa serum) to rat
liver mitochondria, mouse liver mitochondria, human liver mitochondria,
SV 40.induced hamster tumor mitochondria, and the liver mitochondria
of hamsters bearing tumor induced by SV 40 and of hamsters bearing
tumor induced by adenovirus type 12, it became evident that SV 40-tumor
mitochondria reacted on this serum, forming a clear sharp precipitin band
remarkably, and other antigens did not react at all (Fig. 12 & Photo. 10).
In this instance, it is natural that SV40-tumor mitochondria react on this
Fig.12 The result of Ouchterlony central well contains pooled
sera of SV 40-induced tumor-bearing hamsters. Surrounding wells
contain various antigens as illustrated below. NRLM: rat liver
mitochondria. NMLM: mouse liver mitochondria. NHLM: human
liver mitochondria. HaSVTM: SV 40-indLiced hamster tumor mito-
chondria. HaSVLM: SV 40-induced tumor-bearing hamster liver
mitochondria. HaAdLM: adenovirus type 12-induced tumor-bearing
hamster liver mitochondria.
8
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serum, but a question still remains unsolved why mouse liver mitochondria
react on this serum.
As the result of cross.matchings in agar gel diffusion the pooled
sera of hamsters bearing tumor induced by SV 40 to AHl30 rat ascites
hepatoma mitochondria, SR·C3H ascites sarcoma mitochondria, the mito.
chondria of hamster tumor induced by adenovirus type 12, and the liver
mitochondria of rat bearing AH130 hepatoma, of mouse bearing SR-C3H
sarcoma, and hamster bearing tumor induced by adenovirus type 12, it
was clear that the tumor mitochondria of these kinds reacted on such
serum remarkably, forming a clear sharp precipitin band most remarkably.
This facts show that cancer.specific common antigeniciLy c'xists in cancer
mitochondria of various kinds as shown in Figs. 7, 8, 9, and 11. In this
instance, however, a question still remains unsolved why the liver mito-
chondria of mouse bearing SR·C3H sarcoma react on this serum (Fig. 13
& Photo. 11).
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Fig. 13 The result of Ouchterlony central well contains pooled
sera of SV 4O-induced tumor-bearing hamsters. Surrounding wells
contain various antigens as illustrated below. HRTM: AH130 rat
ascites hepatoma mitochondria. MTM : SR-C3H sarcoma mitochondria.
HaAdTM: adenovirus type l2-induced hamster tumor mitochondria.
HRBM: AH130 hepatoma-bearing rat liver mitochondria. RSVTBLM :
SR-C3H sarcoma-bearing hamster liver mitochondria. HaAdLM:
adenovirus type l2-induced tumor-bearingahmster liver mitochondria.
It seems that cancer mitochondria-specific cancer antigenicity existing
in the mitochondria of tumor induced by chemical carcinogens, would also
exist in the mitochondria of tumors induced by viruses. These findings
indicate that it is necessary to investigate what relation the antigenicity
of cancer cell mitochondria would have with the mitochondria of those
relatively immatured and fast dividing cells. But as it was very difficult
to prepare the immature germ cells, the mitochondria of regenerated rat
livers on the second and the 14th day after partial hepatectomia were used
for this purpose.
From the result of cross-matching in agar gel diffusion the rabbit.
antiserum to AH130 hepatoma mitochondria (anti.HMt serum) against
human liver mitochondria, the spleen mitochondria of the same human,
beef heart mitochondria, rat liver mitochondria, and the mitochondria of
regenerated rat liver on the second and the 14th day after partial hepatec-
tomia, the regenerated rat liver mitochondria reacted slightly on this
serum, forming a slight weak precipitin band. It is natural that the regene-
rated rat liver mitochondria have the strong antigenicity common to rat
9
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liver mitochondria, but it is very interesting that the regenerated rad liver
mitochondria show the slight antigenicity common to AH130 rat ascites
hepatoma mitochondria (Fig. 14 & Photo. 12). This is a question which
requires further investigations.
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Fig. 14 The result of Ouchteriony central well contains the rabbit-
antiserum to AHl30 rat ascites hepatoma mitochondria. Surrounding
wells contain various antigens as illustrated below. HLM: human
liver mitochondria. HSM: human spleen mitochondria. BHM: beef
heart mitochondria. RLM: rat liver mitochondria. R*RLM: the
mitochondria of regenerated rat liver on the 2nd day after partial
hepatectomia. R**RLM: the mitochondria of regenerated rat liver
on the 14th day after partial hepatectomia.
DISCUSSION
There are very many reports suggesting that the specific cancer anti-
genicity exists definitely in cancer. Recently, ZILBER (7) reported that the
specific cancer antigens exist in carcinomas induced by chemical carcino-
gens as proven by the anaphylaxic reactions, and PREHN (1960)(37), (1962)
(38), and others (39, 40) reported that the artificial neoplasma acquired
new antigenicities. TAKAYANAGI (1964) (41), (1966) (42) reported that
several specific cancer antigens were found in a 1 to /12 globulin position by
immunoelectrophoretical analyses of the extracted proteins of DAB.hepa.
toma, and DECKER and his collaborator (1966) (43) also reported the exis.
tence of the specific cancer antigens in rat hepatomas by immunodiffu-
sional and immunoelectrophoretical analyses of various tumors, and their
results of immunoelectrophoresis were similar to those of TAKAYANAGI
(41, 42). HIRAI (1966) (44) found the specific cancer antigen in one of the
rat ascites hepatomas and succeeded in crystallizing this antigen.
With a greater attention focused on the intracellular localization of
specific cancer antigens, RAPPORT et al. (2), HORN (3-5), TAKEDA et al. (6),
KIKUCHI (8), and HOKO (9) reported that the cancer cell mitochondria
were the strongest antigenic constituent in the cancer cell. Further, with
an idea that viruses might be one of the causes of cancers, immunofluores.
cent and electron microscopic studies have gained the momentum to look
for in cancer the antigens originating from a virus. Especially, since the
T-antigen was found to be associated with viruses, the investigations in
this field were intensified. HUEBNER and his collaborators (11) reported
that adenovirus specific antigen existed in the nucleus of virus free hamster
tumor and rat tumor by immunofluorescent techniques; BLACE and his
collaborators (13) proved the existence of T-antigen originating from SV
10
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40 in tumor cell induced by SV 40, by immunofluorescent technique;
GILDON and his collaborators (19) stated that in SV 40-induced tumors,
T-antigen existed in both nucleus and cytoplasm immunofluorescently;
POPE and his collaborators (15) also reported that T-antigen originated
from SV 40 exists in SV 40-transformed cell; RAPP and his collaborators
(17) investigated precisely the T-antigen of SV 40 virus and of adenovirus
by the immunofluorescent method; and FOGEL and his collaborator (23)
proved the existence of T-antigen originated from polyoma virus in tumor
cell induced by polyoma virus. Moreover, the movements became active
to investigate T-antigen more precisely at subcellular level. MORGAN and
his collaborators (24) proved electron microscopically the presence of intra-
cellular viral antigen; BLACK and his collaborator (25) the induction of
T-antigen by SV 40-DNA; KALNINS and his collaborators (26,27) reported
a possible existence of virus-associated-antigen originated from adenovirus
type 12; and investigated electron microscopically the localization of T-
antigen in adenovirus type 12-induced tumor cell precisely; LEVINTHAL
and his collaborators (28, 29) investigated in view of the T-antigen of
adenovirus and of SV 40 by ferritin antibody technique; and OSHIRO
and his collaborators (30) the localization of SV 40 viral antigen in tumor
cell induced by SV 40 by the ferritin antibody technique precisely. Now,
those investigators working on viral tumors, would only search for the
conditions under which the viral genome as carcinogen might be incorpo-
rated into cell, while those investigators working on the tumors induced
by chemical carcinogens do not take the participation of viruses into con-
sideration. It will be one way to acertain t he characteristics of cancer, to
investigate what immunochemical changes take place in cancer cell regard-
less of whether the cause of cancer is a virus, chemical substance, or
physical stimulant.
The author holds the opinion that the changes of the cell itself, the
cell transformation to neoplasma, woud occur irrespective of the kinds of
carcinogens, and almost the same changes will be expected immunochemi.
cally to all tumors. If the tumors are different in the immunochemical
nature by differences of carcinogenesis, it may be no exaggeration to say
that we cannot open the way to destroy all the cancers with the same way.
Fortunately, in the previous report (31), it is stated that the highest anti.
genic constituent in membrane systems of cancer cell was the mitochon-
dria; and in another report (32), this cancer mitochondria-specific cancer
antigenicity is common to four different kinds of ascites tumors induced
by chemical carcinogens and the rat, immunized with the mitochondria
of rat ascites hepatoma, rejects the transplantation of the fresh hepatoma
11
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cells. From these facts, it may be thought that a malignant transformed
cell was already changing to the cell which was made by a mould so.called
"cancer" and which had the same antigenic subs!ances partially common
to each other, if its cause to cell transformation is a virus. In the basis of
this, an attention is drawn to the mitochondria of the tumors induced by
viruses in the present report as well in previous reports.
As in obvious from the Figs. 1, 2, 3, and 4, each mitochondrion of
rat ascites hepatoma induced by chemical carcinogens, of hamster tumors
induced by adenovirus and SV 40, and of mouse ascites sarcoma induced
by Rous sarcoma virus, has a strong tumor specificity and this tumor
mitochondria-specific tumor antigenicity is c.:>mmon to all the tumors of
various kinds. Up to date, no investigators have accepted the existence of
tumor-specific common antigen in tumors, except USUBUCHI et at. (45),
reporting that the existence of tumorspecific common antigen might be
thought in order to understand the tumor immunity; and DECKER et at.
(43), about the presence of specific common cancer antigen in various
kinds of rat hepatomas. On the basis of the findings obtained in the
present experiment, it may be reasonable to assert the existence of common
antigenicity in various kinds of tumors cell mitochondria. It was reported
in a previous report that the organ mitochondria-specific antigenicity
of tumor-bearing body was shown in the mitochondria. Thorough-going
investigations of the organ mitochondria-specific antigenicity of animals
bearing tumor induced by viruses or chemical carcinogens have revealed
that the liver mitochondria of AH130 hepatoma-bearing rat show the
antigenicity common to AH 130 hepatoma mitochondria slightly but no
antigenicity common to the liver mitochondria of tumor-bearing body
of other strain, and SR-C3H sarcoma-bearing mouse liver mitochondria
exhibit the antigenicity common to SR-C3H sarcoma mitochondria but no
antigenicity common to the liver mitochondria of tumor-bearing body of
other strain, and adenovirus type l2-induced tumor-bearing hamster liver
mitochondria also show the antigenicity common to the mitochondria of
hamster tumor induced by adenovirus type 12 slightly but no antigenicity
common to the liver mitochondria of tumor-bearing body of other strain,
and SV 40·induced tumor-bearing hamster liver mitochondria also show
the antigenicity common to SV 40-induced hamster tumor mitochondria
but no antigenicity common to the liver mitochondria of tumor-bearing
body of other strain. It is obscure whether the same antigen to cancer cell
mitochondria exists in organ mitochondria of tumor-bearing body, or the
ascites tumor cells infiltrate into the liver because of situated the same
abdominal cavity, judging from the facts that the liver mitochondria of
12
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mouse bearing SR-C3H sarcoma often show the antigenicity common to
other cancer cell mitochondria and the common antigenicity is chiefly
found in the liver of ascites tumor-bearing body, or whether cancerous
changes would take place in the organs of tumor-bearing body by metas-
tasis or cancerous transformation in the organ itself. In this field, DECKER
and his collaborator (43) and others (46-53) reported about the anti-
genicities of the organs of tumor-bearing body. All of them only stated
that the original antigenicities of organ itself diminished at the cancerous
transformation of cells, and there are few precise reports dealing with the
antigenicities of tumors induced by chemical carcinogens as well as of the
tumors induced by viruses especially in mitochondria.
If the antigenic differesnces between normal and cancerous tissue do
not exist, it will not be possible to take adequate measures to cancer
immunochemically. It is very significant that specific tumor antigens are
present and this is the fact that many researchers have searched for them.
In the present series of studies, any specific cancer mitochondrial anti-
genicity has not yet been demonstrated in normal cell mitochondria. It is
recognized that the cancer cell itself has already lost organ-antigenicity at
malignant transformation, and the specific tumor antigenicity has replaced
the original antigenicity. Since the mitochondria of tumors induced by
viruses show the strong antigenicity common to chemical carcinogen-
induced tumor mitochondria, it may be thought that the tumor mitochon-
dria-specific antigenicity common to all the tumor mitochondria will exist
over the strains of animals, but it is a question requiring the further
investigations if this specific antigenicity of tumor mitochondria might
exist commonly in the mitochondria of undifferentiated immature cells.
SUMMARY
The mitochondrial, the microsomal, and the supernatant fractions
were prepared from the cell homogenate of tumors induced by viruses,
such as adenovirus type 12, SV 40, and Rous sarcoma virus, etc. and the
antigenicities of these fractions were investigated. In the virus-induced
tumors, there existed no antigenicity common to the mitochondrial and
the microsomal fractions as in the tumors induced by chemical carcinogens,
and the highest antigenicity was recognized in the mitochondrial fraction.
Therefore, the properties of the tumor cell mitochondria were precisely
investigated with virus-induced tumor mitochondria.
1. The mitochondria of tumors induced by viruses have clearly the
specific antigenicity.
13
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2. This specific antigenicity of virus.induced tumor mitochondria IS
common to all the virus-induced tumors used in the present study.
3. This tumor mitochondria.specific antigenicity is found commonly
III all the tumor mitochondria in the present experiments.
4. The specific cancer antigenicity of tumor cell mitochondria does
not exist in normal organ mitochondria, but the regenerating organ mito.
chondria exhibit a slight antigenicity common to cancer cell mitochondria.
ACKNOWLEDGEMENT
The author wishes to express profound gratitude to Professor T. ODA and Dr. N. TAKA-
YANAGI for helpful comments and kind aid in performing the present investigation. The kind-
ness of Prof. 1'. YAMAMOTO, Department of Oncology, Institute for Medical Science, Uni-
versity of Tokyo, who offered SR-RSV-induced mouse sarcoma is acknowledged.
REFERENCES
I. WITEBSKY, E.: DisponsibiliUit und Spezifitat alcoholloslider Strukturen von Organen und
bosartigen Geschwillsten. Z. 1mmunitiitjorsch. 62, 35, 1929
2. RAPPORT, M. M. and GRAF, L.: Extraction of complement fixing lipid antigens from
mitochondria of Murphy-Sturn lymphosarcoma. Proc. Amer. Ass. Cancer Res. 1, 39, 1954
3. HORN, E. C.: In vivo effect of nucleoprotein from Ehrlich ascites tumor cells. Biochim.
et Biophys. Acta 16, 440, 1955
4. HORN, E. C.: Ascites tumor development I. An analysis of in vivo effect of nucleopro-
tein from Ehrlich ascites cells. Cancer Res. 15, 663, 1955
5. HORN, E. C.: Ascites tumor development II. Cytotoxicity of various antisera prepared
against Ehrlich ascites tumor cell component. Cancer Res. 16, 595, 1956
6. TAKEDA, K., YOSH10, H. and SAKATA, Y.: Immunopathological studies on the speci-
ficity of the tumor antigen of rat treated with TCA. Gann 47, 549, 1956
7. ZILBER, L. A.: Specific tumor antigens. Advance Cancer Res. 5. 291, (1958)
8. KIKUCHI, K.: The intracellular localization of tumor specific antigens of rat tumor. Cann
no rinsho 8, 639, 1962
9. HOKO, T.: Immunochemical analysis of mitochondrial fraction from cancer cells. juzen
Igaku Zasshi 74, (No.1), 30, 1966
10. RUBIN, H.: Influence of tumor virus infection on the antigenicity and behavior of cells.
Cancer Res. 21, 1244, 1960
II. HUEBNER, R.J., ROWE, W. P., TURNER, H. C. and LANE, W. T.: Specific adenovirus
complement fixing antigens in virus-free hamster and tumors. Proc. Nat. Acad. Sci. 50,
379, 1963
12. HUEBNER, R.J., CHANOCK, R. M., RUBIN, B. A. and CASY, M.J.: Induction by adeno-
virus type 7 of tumors in hamsters having the antigenic characteristics of SV40 virus.
Proc. Nat. Acad. Sci. 52, 1333, 1964
13. BLACK, H., ROWE. W. P., TURNER, H. C. and HUEBNER, R. T.: A specific complement
fixing antigen present in SV 40 tumor and transformed cells. Proc. Nat. Acad. Sci. 50,
1148, 1963
14. BLACK, P. H., LEWIS, A. M. Jr., BLACKLOW, N. R., AUSTIN, J. B. and ROWE, W. P.:
The presence of adenovirus-speciffc antigens in hamster cells rendered neoplastic by adeno-
virus 1-SV40 and adenovirus 2-SV40 hybrid viruses. Proc. Nat. Acad. Sci. 57 (No.5),
14
Acta Medica Okayama, Vol. 23 [1969], Iss. 2, Art. 4
http://escholarship.lib.okayama-u.ac.jp/amo/vol23/iss2/4
Immunospecificity of Tumor Cell Mitochondria 119
1324, 1967
15. POPE, J. H. and ROWE, W. P.: Detection of specific antigen in SV40-transformed cells
by immunofluorescence. j. Exptl. Med. 120, 121, 1964
16. RAPP, F., KITAHARA, T., BUTEL, J. S. and MELNICK, J. L.: Synthesis of SV40 tumor
antigen during replication of Simian papovavirus (SV40). Proc. Nat. AGad. Sci. 52, 1138,
1964
17. RAPP, F. and MELNICK, J. L.: The footprints of tumor viruses. SGientific American 214
(3), 34, 1966
18. SABIN, A. B. and KOCH, M. A.: Source of genetic information for specific complement-
fixing antigens in SV40 virus induced tumors. Proc. Nat Acad. Sci. 52, 1131, 1964
19. GILDEN, R. V., CARP, R. 1., TAGUCHI, F. and DEFENDI, V.: The nature and locali·
zation of the SV40-induced cr /Hplement fixing antigen. Proc. Nat. Acad. Sci. 53, 684,
1965
20. HOGGAN, M. D., ROWE, W. P., BLACK, P. H. and HUEBNER, R. 1.: Production of
"tumor specific" antigens by oncogenic viruses during acute cytolytic infections. Proc.
Nat. Acad. Sci. 53, 12, 1965
21. OXMAN, M. N. and BLACK, P. H.: Inhibition of SV40 T-antigen formation by inter-
feron. Proc. Nat. Awd. Sci. 55, 1133, 1966
22. PASTERNAK, G.: Defferentiation between viral and new cellular antigens in Graffi
leukaemia of mice. Nature 214 (No. 5095), 1364, 1967
23. FOGEL, M. and GILDEN, R.: Polyoma virus-induced .• complement-fixing antigen" in
tumors and infected cells as detected by immunofluorescence. Ptoc. Soc. Exp. Bio. M ed.
124 (No.4), 1047, 1967
24. MORGAN, C., RIFKIND, R. A., Hsu, K. C., HOLDEN, M., SEEGAL, B. C. and ROSE, H.
M.: Electron microscopic localization of intracellular viral antigen by the use of ferritin-
conjugated antibody. Virology 14, 292, 1961
25. BLACK, P. H. and ROWE, W. P.: Induction of SV40 T antigen with SV40 DNA.
Virology 27, 436, 1965
26. KALNINS, V. 1., STICH, H. F. and YOHN, D. S.: Electron microscopic localization of
virus associated antigen in human amnion cells (A-V-3) infected with human adenovirus
type-12. Virology 28, 751, 1966
27. KALNINS, V. 1., STICH, H. F., GRECORY, C. and YOHN, D. S.: Localization of tumor
antigens in adenovirus-12-induced tumor cells and in adenovirus-12 infected human and
hamster cells by ferritin-labeled antibodies. Cancer Res. 27, 1874, 1967
28. LEVINTHAL, J. D., CEROTTINI, J. C., AHMAD-ZADEH, C. and WICKER, R.: The detec-
tion of intracellular adenovirus type 12 antigens by indirect immunoferritin technique.
International j. of Cancer 2 (No.2), 85, 1967
29. LEVINTHAL, J. D., WICKER, R. and CEROTTINI, J. C.: Study of intracellular SV40
antigen by indirect immunoferritin technique. Virology 31 (No.3), 555, 1967
30. OSHIRO, L. S., ROSE, H. M., MORGAN, C. and Hsu, K. C.: The localization of SV40-
induced neoanfigen with ferritin-labeled antibody. Virology 31 (No. 1), 183, 1967
31. WAKABAYASHI, A.: Immunological studies on the membrane systems of cancer cells. 1.
Immunochemical analysis of membrane fractions from cancer cells. Acta Med. Okayama
22, 1968
32. WAKABAYASHI, A.: Immunological studies on the membrane systems of cancer cells. II.
Immunochemical specificities of the mitochondria from carcinoma cells induced by
chemical carcinogens. Acta Med. Okayama 23, 1969
33. YAMAMOTO. T. and TAKEUCHI, M.: Studies on Rous sarcoma virus in mice 1. Estab-
lishment of an ascites sarcoma induced by Schmidt-Ruppin strain of Rous Sarcoma
Virus in C3H/He mouse. japan j. E>.p. Med. 37, 43, 1967
15
Wakabayashi: Immunological studies on the membrane systems of cancer cells. 3.
Produced by The Berkeley Electronic Press, 1969
120 A. WAKABAYASHI
34. TAKEUCHI, M., HINO, S. and YAMAMOTO, T.: Studies on Rous sarcoma virus in mice
II. Clonal analysis of cell population of the SR-RSV-Induced Ascites Sarcoma (SR-
C3H/He Ascites). japan j. Exp. Med. 37, 107, 1967
35. HOGEBOOM, G. H.: Fractionation of cell component of animal tissues. Methods in En<:y-
mology, vol. 1, p.16, Academic Press. New York, 1955
36. KABAT, E. A. and MAYER, M. M.: "Experimental immunochemistry" 2nd edition, p. 22,
CHARLES, C. THOMAS, Publisher, Springfield, Illinois, U. S. A. 1964
37. PREHN, R. T.: Tumor-specific immunity to transplanted dibenzanthracene-induced
sarcoma. Cancer Res. 20, 1614, 1960
38. PREHN, R. T.: Specific isoantigenicities among chemically induced tumors. Ann. N. Y.
Acad. Sci. 101, 107, 1962
39. HADDOW, A.: Immunology of the cancer cell: Tumor specific antigens. Brit. Med. Bull.
21, 133, 1965
40. GORDON, J.: Isoantigenicity of tumor induced by an Azo dye. Brit. j. Cancer 19, 387,
1965
41. TAKAYANAGI, N.: Study on the extracts from DAB-hepatoma of rat by immunodiffusion
methods. jahresbricht des Kurashiki-Zentralhospitalis, Jg. 33, (Nr.2), 190, 1964
42. TAKAYANAGI, N.: Immunological analysis of extracts from livers in the couse of carcino-
genesis. Cann 57 (No.6), 577, 1966
43. DECKER, C and DECKERS-PASSAU, LILIANE, (Belgium): Specific tumor antigens in rat
hepatomas and leucosarcomas. Specific Tumor Antigens vol. 1, p. 34, A symposium organized
by the International Union against Cancer and the U. S. S. R. Academy of Medical
Science, 1966
44. HIRAI, H.: Specific antigenic proteins of rat ascites hepatoma. Specific Tumor Antigens
vol. 1, p. 42, A symposium organized by the International Union against Cancer and
the U. S. S. R. Academy of Medical Science, 1966
45. USUBUCHI, 1., SOBAJIMA, Y., KUDO, H., HONGO, T. and SUGAWARA, M.: Inhibition
against autotransplantation of mouse mammarial carcinomas by the cross-immunization.
igaku-no-ayumi 61 (No. 11), 692, 1967
46. WEILER, E.: Die Anderung der serologischen Organspezifitat beim Butter-Gelb Tumor
der Ratte im vergleichzu normaler Leber. Z. Naturforsch. 7, 324, 1952
47. NAIRN, R. C., RICHMOND, H. G. and FOTHERGILL, J. E.: Differences in staining of
normal and malignant cell by non-immune fluorescent protein conjugates. Brit. Med. j.
1, 1341, 1960
48. NAIRN, R. C., FOTHERGILL, J. E. and McENTEGART, M. G.: Loss of gastrointestinal
specific antigens in neoplasma. Brit. Med. j. 2, 1791, 1962
49. KAYE, H. E. M. and WALLACE, D. M.: A and B antigens arising from urinary epithelium.
j. Nat. Cancer inst. 26, 1349, 1961
50. NELKEN, D.: Loss of leucocyte individual specific antigens in disease of acute leukemia.
Vox. Sang. 8, 638, 1963
51. DAO, T. L., TANAKA, Y. and GAWLAK, D.: Effect of polycyclic hydrocarbons on
mammary homograft-survival and tumorigenesis in rats. j. Nat. Cancer inst. 33, 963,
1964
52. AMOS, D. B., HATTLER, B. G. and SHINGLETON, W. W.: Prolonged survival of skin
grafts from cancer patients on normal recipients. Lancet 1, 414, 1965
53. HUR, N. B., BIRAN, S. and ROBINSON, E.: Comparison of the survival of skin grafts
from normal mice and mice with Ehrlich ascites tumor. Transplantation 4, 205, 1966
16
Acta Medica Okayama, Vol. 23 [1969], Iss. 2, Art. 4
http://escholarship.lib.okayama-u.ac.jp/amo/vol23/iss2/4
Immunospecificity of Tumor Cell Mitochondria
LEGENDS FOR PHOTOGRAPHS
121
The photographs are the results obtained by Ouchterlony agar double diffusion test.
Photo. I Central well contains the rabbit-antiserum to AHl30 rat ascites hepatoma mito-
chondria. Surrounding wells contain various antigens as illustrated below. I: SR-
C3H sarcoma mitochondria. 2: SR-C3H sarcoma microsomes. 3: SR-C3H cell
homogenate. 4: the supernatant of SR-C3H sarcoma. 5: SR-C3H sarcoma-bearing
mouse liver mitochondria. 6: SR-C3H sarcoma-bearing mouse liver microsomes.
Photo. 2 Central well contains the rabdit-antiserum to SR-C3H sarcoma mitochondria. Sur-
rounding wells contain various antigens as illustrated below. I: SR-C3H sarcoma
mitochondria. 2: SR-C3H sarcoma microsomes. 3: SR-C3H cell homogenate.
4: the supernatant of 105,000 x g, 30 min. of SR-C3H sarcoma. 5: SR-C3H-
bearing mouse liver mitochondria. 6: SR-C3H-bearing mouse liver microsomes.
Photo. 3 Central well contains the rabbit-antiserum to SR-C3H sarcoma mitochondria.
Surrounding wells contain various antigens as illustrated below. RS: SR-C3H
sarcoma mitochondria. Ad: adenovirus type 12-induced hamster tumor mitochon-
dria. H: AHl30 rat ascites hepatoma mitochondria. Rn: AHl30 hepatoma-bearing
rat liver mitochondria. Mn: SR-C3H sarcoma-bearing mouse liver mitochondria.
Hn: adenovirus type 12-induced tumor-bearing hamster liver mitochondria.
Photo. 4 Central well contains the rabbit-antiserum to AH 130 rat ascites hepatoma mito-
chondria. Surrounding wells contain various antigens as illustrated below. HRTM:
AHl30 hepatoma mitochondria. MTM: SR-C3H sarcoma mitochondria. adHaTM:
adenovirus type 12-induced hamster tumor mitochondria. HRBM: AHl30 hepa-
toma-bearing rat liver mitiochondria. SRVMBL: SR-C3H sarcoma-bearing mouse
liver mitochondria. adHaBM: adenovirus type 12-induced tumor-bearing hamster
liver mitochondria.
Photo. 5 Central well contains the rabbit-antiserum to AHl30 rat ascites hepatoma mito-
chondria. Surrounding wells contain various antigens as illustrated below. HRTM:
AHl30 hepatoma mitochondria. MTM: SR·C3H sarcoma mitochondria. adHaTM:
adenovirus type 12-induced hamster tumor mitochondria. HLM: human liver
mitochondria. BHM: beef heart mitochondria. RLM: rat liver mitochondria.
Photo. 6 Central well contains the rabbit-antiserum to SR-C3H sarcoma mitochondria.
Surrounding wells contain various antigens as illustrated below. HRTM: AHl30
hepatoma mitochondria. MTM: SR-C3H sarcoma mitochondria. HaAdTM:
adenovirus type 12-induced hamster tumor mitochondria. HBRM: AHl30 hepa-
toma-bearing rat liver mitochondria. RSVTBMLM: SR-C3H sarcoma-bearing
mouse liver mitochondria. HaAdLM: adenovirus type 12-induced tumor-bearing
hamster liver mitochondria.
Photo. 7 Central well contains pooled sera of adenovirus t~pe 12-induced tumor-bearing
hamsters. Surrounding wells contain various antigens as illustrated below. HRTM:
AHl30 hepatoma mitochondria. MTM: SR-C3H sarcoma mitochendria. adHaTM:
adenovirus type 12-induced hamster tumor mitochondria. FRBM: AH66F hepa-
toma-bearing rat liver mitochondria. RSVMBL: SR-C3H sarcoma-bearing mouse
liver mitochondria. adHaBM: adenovirus type 12-induced tumor-bearing hamster
liver mitochonbria.
Photo. 8 Central well contains pooled sera of adenovirus type 12-induced tumor-bearing
hamsters. Surrounding wells contain various antigens as illustrated below. NRLM:
rat liver mitochondria. NMLM: mouse liver mitochondria. NHLM: human liver
mitochondria. HSM: human spleen mitochondria. HaSVLM: SV 4O-induced
17
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tumor-bearing hamster liver mitochondria. RSVTBMLM: SR-C3H sarcoma-bear-
ing mouse liver mitochondria.
Photo. 9 Central well contains pooled sera of adenovirus type 12-induced tumor-bearing
hamsters. Surrounding wells contain various antigens as illustrated below. RS:
SR-C3H sarcoma mitochondria. Ad: adenovirus type 12-induced hamster tumor
mitochondria. H: AHl30 hepatoma mitochondria. Rn: rat liver mitochondria.
Mn: mouse liver mitochondria. Hn: hamster liver mitochondria.
Photo. 10 Central well contains pooled sera of SV 40-induced tumor-bearing hamsters.
Surrounding wells contain various antigens as illustrated below. NRLM: rat liver
mitochondria. NMLM: mouse liver mitochondria. NHLM: human liver mito-
chondria. HaSVTM: SV 4O·induced hamster tumor mitochondria. HaSVLM:
SV 40-induced tumor-bearing hamster liver mitochondria. HaAdLM: adenovirus
type 12-induced tumor-bearing hamster liver mitochondria.
Photo. 11 Central well contains pooled sera of SV 40-induced tumor-bearing hamsters.
Surrounding wells contain various antigens as illustrated below. HRTM: AHl30
hepatoma mitochondria. MTM: SR-C3H sarcoma mitochondria. HaAdTM:
adenovirus type 12-induced hamster tumor mitochondria. HRBM: AHl30 hepa-
toma-bearing rat liver mitochondria. SRVTBLM: SR-C3H sarcoma-bearing mouse
liver mitochondria. HaAdLM: adenovirus type 12-induced tumor-bearing hamster
liver mitochondria.
Photo.12 Central well contains the rabbit-antiserum to AHl30 rat ascites hepatoma mito-
chondria. Surrounding well., contain various antigens as illustrated below. HLM:
human liver mitochondria. HSM: human spleen mitochondria. BHM: beef heart
mitochondria. RLM: rat liver mitochondria. R*RLM: the mitochondria of
regenerated rat liver on the 2nd day after partial hepatectomia. R **RLM: the
mitochondria of regenerated rat liver on the 14th day after partial hepatectomia.
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